MedPath

Effects of estrogen supplementation for patients with thin endometrial lining receiving oral clomiphene citrate

Not Applicable
Conditions
Primary or secondary subfertility
Urological and Genital Diseases
Registration Number
ISRCTN10360127
Lead Sponsor
niversity Malaya Medical Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
Female
Target Recruitment
124
Inclusion Criteria

Women diagnosed with primary or secondary subfertility undergoing ovulation induction using clomiphene citrate in preparation for intrauterine insemination (IUI) or timed sexual intercourse (TSI)

Exclusion Criteria

1. Planned IVF
2. Diagnosed with an endometrial polyp
3. Using GnRH Agonist
4. Systemic diseases (e.g. autoimmune, cardiac, liver, thyroid disease or malignancy)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath